Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Special Report on African Mango By PowerSupplements.Com Looks to Uncover Facts

 

Perfect African Mango




African Mango and Dr Oz


(EMAILWIRE.COM, April 12, 2012 ) New York, NY -- There is one indisputable fact about African Mango – it is controversial! On one side, people claiming that African Mango (or Irvingia Gabonensis) is the most powerful weight loss supplement to come around in years. On the other side are the people who see African Mango as just the latest “miracle pill” that will only help lose weight in the wallet.



To help separate fact from fiction when it comes to the African Mango, PowerSupplements.Com has just completed on special report on African Mango supplements and research. The purpose of the report is to provide objective, unbiased information on African Mango and African Mango supplements, so consumers can make well informed decisions.



In the African Mango Special Report PowerSupplements addresses topics such as:



· Does African Mango Really Help With Weight Loss?

· What Did Dr. Oz Really Say About African Mango?

· Has An African Mango Dosage Been Established?

· Are All African Mango Supplements The Same?

· What is IGOB131 And Why Is It Important?

· Have There Been Clinical Studies done On African Mango?



“The point of the report is to establish what we know and don’t know about African Mango and African Mango Supplements as it pertains to weight loss. There is so much wrong and misleading information online, we wanted to provide a good starting point for people looking to learn more about African Mango” states Bob Peters, Director of Communications for PowerSupplements.Com .



African Mango exploded on the scene when Dr. Oz mentioned it on his show in May 2011. The Doctor Oz show focused on products that could help woman over the age of 40. In the segment, Dr Oz, talked about how African Mango could help women lose 10 pounds. Ever since that show aired, that has been tremendous interest in African Mango and African Mango supplements.



Even before Dr Oz picked up on African Mango, there was a great deal of buzz due to a a study published in the Journal of Lipids and Disease. In the study, a group of overweight adults who took IGOB131 (an African Mango seed extract), twice a day (150mg per serving), lost significantly more weight than the group taking a placebo. At the end of 10 weeks, the IGOB131™ group lost an average of 28 pounds, 6.7 inches from their waistline and reduced body fat by 18.4%.

Peters concludes, “African Mango is a very interesting ingredient and the initial clinical studies have been strong. People do need to learn the difference between IGOB131 and other African Mango supplements. We hope our special report will provide the necessary information to get people going on African Mango.”



About PowerSupplements:



PowerSupplements.Com is the site where science and supplements meet. PowerSupplements provides research and information on the most popular nutritional supplements so that consumers can make informed decisions. PowerSupplements.Com has been providing information and research since 1999.



For More Information Please Visit http://www.powersupplements.com

PowerSupplements
Bob Peters
(212) - 535 - 5083
questions@powersupplements.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Five dead, dozens sickened by listeria linked to caramel apples
19 Dec 2014 at 7:37am
(Reuters) - Five people have died and 21 others have been hospitalized in recent weeks in a listeria outbreak linked to caramel apples, health officials said on Friday. A total of 28 people infected with listeria have been reported from 10 states, according to a statement from the U.S. Centers for Disease Control. The CDC warned consumers not to eat any pre-packaged, commercially-produced caramel apples, including those with other toppings such as nuts, chocolate or sprinkles, until more information is available. ...


Mozambique decriminalises abortion to stem maternal deaths
19 Dec 2014 at 7:34am

Mozambique has passed a law permitting women to terminate unwanted pregnancies under specified conditions without risking punishment, a move hailed by activists in a country where clandestine abortions account for a large number of maternal deaths. President Armando Guebuza on Thursday quietly signed into law a revised penal code bill that eases prohibitions in abortion regulations. In Mozambique, the earlier law outlawing abortion, except in cases where the mother?s life or health is endangered, dates to the late 19th century, when the mainly Catholic Portuguese controlled the country. The other major creed in Mozambique is Islam, a faith which also does not support abortion.



The 12 Days of a Healthy Home: A Holiday Checklist
19 Dec 2014 at 7:27am

The 12 days of Christmas are fast approaching. While five golden rings would be lovely, most of us have no use for two turtle doves, or a partridge. What we do seek, and at the top of most people's wish list these days, is good health. Why then, do we adorn our homes with holiday décor and engage in activities that could be making the whole...



What Really Matters Today (And Every Day)
19 Dec 2014 at 7:06am

As I write this, one of my daughters is in the hospital recovering from elective, but nonetheless somewhat urgent surgery. She will be fine, and likely come home later today. Still, the native rhythms of Katz family holiday preparation are much disturbed by worry, and the logistics of a family member in the hospital. When another of our...



The Science of Fat: What We Don't Know Will Hurt You
19 Dec 2014 at 7:00am

The following is the introduction to the chapter "The Science of Fat" in the book Fat Kids: Truth and Consequences. Why we become fat and how we lose fat is of primary interest in our culture and our homes. What we don't know may surprise you. It is far more complex than even scientists currently know. This is just the beginning of an extensive...



Wall Street little changed after two-day run
19 Dec 2014 at 6:58am

NEW YORK (Reuters) - U.S. stocks were little changed on Friday, after the Federal Reserve's most recent policy statement sparked the best two-day run for the benchmark S&P 500 in three years.


Avoid the Second Mistake
19 Dec 2014 at 6:53am
So often, we make the mistake of believing that sticking to good habits is an all-or-nothing game. (I say "we" because I've been there before as well.)We assume that if we slip up on our diet, then we have ruined the whole thing.We act like missing one day of writing means we simply weren't meant to be a writer.We use our lack of motivation to...

Tennessee GOP leader drafts bill to ensure accused truants get attorneys
19 Dec 2014 at 6:49am
A Tennessee state legislator is concerned that accused truants can be prosecuted without having counsel to aid them in court

European regulators recommend approval of Orexigen's obesity pill
19 Dec 2014 at 5:24am
(Reuters) - European regulators recommended the approval of Orexigen Therapeutics Inc's diet pill, which could become the first prescription medicine for obesity to be approved in the European Union in nearly a decade. The drug, sold as Contrave by partner Takeda Pharmaceutical Co in the United States, will be marketed as Mysimba in Europe. The European Commission is expected to give its decision on the drug in early 2015, Orexigen said. The treatment, which won U.S. ...

Novo Nordisk gets positive opinion on Tresiba for children in Europe
19 Dec 2014 at 5:12am
COPENHAGEN (Reuters) - Drug maker Novo Nordisk said the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the use of its diabetes drug Tresiba for the treatment of children and adolescents. An European Commission approval of the label expansion means physicians in the European Union will be able to prescribe Tresiba to children with type 1 and type 2 diabetes, Denmark's Novo Nordisk said in a statement on Friday. ...

Europe recommends approval for first stem-cell therapy
19 Dec 2014 at 5:08am
LONDON (Reuters) - European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye. The European Medicines Agency said on Friday that Holoclar, from privately held Italian company Chiesi, had been given a green light for moderate to severe limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness. Holoclar is a living tissue product made from a biopsy taken from a small undamaged area of the patient?s cornea and grown in the laboratory using cell culture. ...

Philippine health minister resigns over vaccine purchase
19 Dec 2014 at 5:01am
MANILA (Reuters) - Philippine President Benigno Aquino has accepted the resignation of his health minister over the purchase of pneumonia vaccines in 2012 which government investigators later questioned, a spokesman said on Friday. Health Secretary Enrique Ona, who has been on leave since October, submitted his letter of resignation on Thursday even before the completion of a government inquiry into four deals at his ministry. "The President has accepted his resignation effective today," Herminio Coloma, the president's press secretary, told reporters in a text message. ...


Double blow for Roche as breast cancer, Alzheimer's studies fail
19 Dec 2014 at 4:58am

By Silke Koltrowitz and Ben Hirschler ZURICH/LONDON (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years. The Swiss drugmaker said it was ending a late-stage study of experimental Alzheimer's drug gantenerumab after it failed to prove effective, underlining the difficulty of treating the memory-robbing disease and removing "blue sky" upside for the shares. ...


Orexigen diet pill recommended for approval in Europe
19 Dec 2014 at 4:49am
LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday. The drug, known as Contrave in the United States, will be marketed as Mysimba in Europe. The medicine won U.S. approval in September and is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence. ...

School Takes Away Blind Boy's Cane as Punishment for Acting Up
19 Dec 2014 at 4:19am
A school took away an 8-year-old blind boy's cane as punishment for acting up and replaced it with a pool noodle, his father told ABC News.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC